Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Which Dividend Etf Has Lowest Expense Ratio introduces side-by-side comparisons to spot the cheapest options for cost-conscious investors.
27,554 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
The stock market has shown impressive strength, but political forces and monetary policy tensions can tilt the landsc...
Redwire’s backlog and contract wins are lifting the stock, but the company remains unprofitable. This report weighs t...
Ferrari stock has fallen about 33% from its July 2025 peak, but a deeper look shows the market may be mispricing the ...
Investors have watched Comfort Systems soar in recent years. This guide evaluates whether should comfort systems stoc...
Berkshire Hathaway sits on a large cash cushion while markets move. This article breaks down why patience can shape b...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
A stock rising 58% this year can signal momentum or a looming reversal. This guide helps you evaluate whether it rema...
Carvana's board approved a 5-for-1 stock split, pending shareholder approval. The move could widen access for retail ...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...
A lesser-known chip stock is catching the AI wave’s spotlight. This article breaks down why it’s rallying, what fuels...